These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24892950)

  • 1. A more generalizable method to evaluate changes in health care costs with changes in health risks among employers of all sizes.
    Musich S; White J; Hartley SK; Bhattarai GR; Hawkins K; Ozminkowski RJ
    Popul Health Manag; 2014 Oct; 17(5):297-305. PubMed ID: 24892950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A more generalizable method to evaluate the association between commonly reported health risks and health care expenditures among employers of all sizes.
    White J; Hartley SK; Musich S; Hawkins K; Ozminkowski RJ
    J Occup Environ Med; 2013 Oct; 55(10):1179-85. PubMed ID: 24064775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research Committee.
    Anderson DR; Whitmer RW; Goetzel RZ; Ozminkowski RJ; Dunn RL; Wasserman J; Serxner S;
    Am J Health Promot; 2000; 15(1):45-52. PubMed ID: 11184118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health risk appraisals: how much do they influence employees' health behavior?
    Huskamp HA; Rosenthal MB
    Health Aff (Millwood); 2009; 28(5):1532-40. PubMed ID: 19738273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten modifiable health risk factors are linked to more than one-fifth of employer-employee health care spending.
    Goetzel RZ; Pei X; Tabrizi MJ; Henke RM; Kowlessar N; Nelson CF; Metz RD
    Health Aff (Millwood); 2012 Nov; 31(11):2474-84. PubMed ID: 23129678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The magnitude and nature of risk selection in employer-sponsored health plans.
    Nicholson S; Bundorf K; Stein RM; Polsky D
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1817-38. PubMed ID: 15533189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between health risks and medical expenditures in a Japanese corporation.
    Lynch WD; Chikamoto Y; Imai K; Lin TF; Kenkel DS; Ozminkowski RJ; Goetzel RZ
    Am J Health Promot; 2005; 19(3 Suppl):238-48. PubMed ID: 15675538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience with employee choice of consumer-directed health plans and satisfaction with enrollment.
    Fowles JB; Kind EA; Braun BL; Bertko J
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1141-58. PubMed ID: 15230917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported health risks linked to health plan cost and age group.
    Hill RK; Thompson JW; Shaw JL; Pinidiya SD; Card-Higginson P
    Am J Prev Med; 2009 Jun; 36(6):468-74. PubMed ID: 19460654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lifestyle-disease diagnosis or risk status and medical care costs in a Japanese corporation.
    Nishimura Y; Chikamoto Y; Arima H
    Am J Health Promot; 2005; 19(3 Suppl):249-54. PubMed ID: 15675539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive validity of the HERO Scorecard in determining future health care cost and risk trends.
    Goetzel RZ; Henke RM; Benevent R; Tabrizi MJ; Kent KB; Smith KJ; Roemer EC; Grossmeier J; Mason ST; Gold DB; Noeldner SP; Anderson DR
    J Occup Environ Med; 2014 Feb; 56(2):136-44. PubMed ID: 24451607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical cost savings for web-based wellness program participants from employers engaged in health promotion activities.
    Williams LC; Day BT
    Am J Health Promot; 2011; 25(4):272-80. PubMed ID: 21361813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk selection in employer-sponsored managed care plans.
    Marchetta M
    Find Brief; 2005 Sep; 8(5):1-5. PubMed ID: 16145791
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
    Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
    J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between 11 health risks and medical and productivity costs for a large employer.
    Kowlessar NM; Goetzel RZ; Carls GS; Tabrizi MJ; Guindon A
    J Occup Environ Med; 2011 May; 53(5):468-77. PubMed ID: 21562464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of employee benefit costs by age.
    Rappaport A
    Soc Secur Bull; 2000; 63(4):47-56. PubMed ID: 11641988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between modifiable health risk factors and medical expenditures, absenteeism, short-term disability, and presenteeism among employees at novartis.
    Goetzel RZ; Carls GS; Wang S; Kelly E; Mauceri E; Columbus D; Cavuoti A
    J Occup Environ Med; 2009 Apr; 51(4):487-99. PubMed ID: 19337132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.